pharmaphorum September 27, 2021
As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials.
The pharmaceutical industry is one of the most important industries in the world, providing lifesaving drugs and treatment to people who need it the most. This already significant industry is growing – it is estimated to be worth $1.27 trillion by end of 2020. But despite reaching billions of people around the world, it has not necessarily met the needs of every patient from every background.
The issue of better diversity and inclusion has been a focus for organisations, businesses, policy makers and people from all walks of life in recent years. As people...
Today's Sponsors
Today's Sponsor